Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer

被引：0
|
作者：
Shinkichi Takamori
Mototsugu Shimokawa
Taichi Matsubara
Naoki Haratake
Ryo Toyozawa
Naoko Miura
Masafumi Yamaguchi
Takashi Seto
Tetsuzo Tagawa
Tatsuro Okamoto
Mitsuhiro Takenoyama
Yoshihiko Maehara
Masaki Mori
机构：
[1] National Hospital Organization Kyushu Cancer Center,Department of Thoracic Oncology
[2] Yamaguchi University Graduate School of Medicine,Department of Biostatistics
[3] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[4] Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Surgery
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
Non-small cell lung cancer; Smoking; Surgery; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：685 / 694
页数：9
相关论文
共 50 条
  • [31] The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer
    Shuichi Shinohara
    Ryo Otsuki
    Kenichi Kobayashi
    Masaki Matsuo
    Ken Harada
    Masakazu Sugaya
    Makoto Nakagawa
    Annals of Surgical Oncology, 2020, 27 : 481 - 489
  • [32] The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer
    Shinohara, Shuichi
    Otsuki, Ryo
    Kobayashi, Kenichi
    Matsuo, Masaki
    Harada, Ken
    Sugaya, Masakazu
    Nakagawa, Makoto
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (02) : 481 - 489
  • [33] Prognostic Impact of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer
    Tuminello, S.
    Veluswamy, R.
    Petralia, F.
    Wang, P.
    Flores, R.
    Van Gerwen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S254 - S255
  • [34] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [35] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [36] IMMUNE MARKERS IN SURGICALLY RESECTED EARLY STAGE NON-SMALL CELL LUNG CANCER PATIENTS
    Uysal, Pelin
    Kilic, Burcu
    Demirkaya, Ahmet
    Afsar, Cigdem Usul
    Karaca, Feryal
    ACTA MEDICA MEDITERRANEA, 2019, 35 (01): : 65 - 69
  • [37] The value of tumor volume in surgically resected non-small cell lung cancer
    Iwasaki, A
    Shirakusa, T
    Enatsu, S
    Maekawa, S
    Hamada, T
    Hamasaki, M
    THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (02): : 112 - 116
  • [38] Impact of smoking on mortality of patients with non-small cell lung cancer
    Lee, Seung Jun
    Lee, Jinwoo
    Park, Young Sik
    Lee, Chang-Hoon
    Lee, Sang-Min
    Yim, Jae-Joon
    Yoo, Chul-Gyu
    Han, Sung Koo
    Kim, Young Whan
    THORACIC CANCER, 2014, 5 (01) : 43 - 49
  • [39] Impact of preoperative comorbidities on postoperative complication rate and outcome in surgically resected non-small cell lung cancer patients
    Benker, Martina
    Citak, Necati
    Neuer, Thomas
    Opitz, Isabelle
    Inci, Ilhan
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2022, 70 (03) : 248 - 256
  • [40] Clinical Impact of Histologic Type in Patients with Surgically Resected Stage II and III Non-small Cell Lung Cancer
    Kim, H. R.
    Yun, J. K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S294 - S295
12345